我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

Ivermectin in COVID-19 Patients a Multicenter: Retrospective Study

Alonso Luis, Bracho Colina Wilmer, Carvallo Hector, Del Franco Haroldo, Hirsch Roberto, Salgado Antonio and Shaikh Sanjid Seraj

During 2020, many Medical Centers and solo Practitioners have adopted the I.D.E.A. protocol (Ivermectin, Dexamethasone, Enoxaparin and Aspirin) as the only inexpensive, effective, safe means to fight COVID infection. We hereby summarize the experience of some of these endeavors, stressing the fact that -by providing their patients with this protocol they have saved thousands of lives that, if not, would have been put in an unnecessary danger, or simple lost. We take into consideration the percentage of COVID+ patients that required ulterior admittance, and also the death rate amid those admitted.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。